A biotech startup called Vivodyne says the AI drug-discovery industry has a data problem, and that it has built a machine to fix it.
HIVE, modular robotic labs built by the company, can grow 20 kinds of human tissue, then autonomously dose and monitor them, generating the kind of causal biological data that today’s AI models are missing — data that today mostly comes from animal testing, or studies of single cells or proteins, not living tissue.